COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-CD123 IMMUNOTHERAPY
Canada
3113058
Filed on 2021-03-16
3113058
Filed on 2021-03-16
USES OF MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS
US Application 18/318588
Filed on 2023-05-16
Filed on 2023-05-16
METHOD OF SELECTING T CELLS WITH IMPROVED ANTI-CANCER ACTIVITY
US Application 18/251,751
Filed on 2023-05-04
Filed on 2023-05-04
METHOD OF SELECTING T CELLS WITH IMPROVED ANTI-CANCER ACTIVITY
Patent Cooperation Treaty
PCT/EP2021/080796
Filed on 2021-11-05
PCT/EP2021/080796
Filed on 2021-11-05
M971 CHIMERIC ANTIGEN RECEPTORS
US Application 18/502,993
Filed on 2023-11-06
Filed on 2023-11-06
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
New Zealand
805541
Filed on 2023-11-15
805541
Filed on 2023-11-15
TASPASE1 INHIBITORS AND USES THEREOF
European Patent
20889515.1
Filed on 2020-11-20
20889515.1
Filed on 2020-11-20
TASPASE1 INHIBITORS AND USES THEREOF
US Application 17/777,971
Filed on 2022-05-18
Filed on 2022-05-18
TASPASE1 INHIBITORS AND USES THEREOF
China
202080092864.4
Filed on 2020-11-20
202080092864.4
Filed on 2020-11-20
TASPASE1 INHIBITORS AND USES THEREOF
Australia
2020386081
Filed on 2020-11-20
2020386081
Filed on 2020-11-20